Overview

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Status:
Active, not recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
Phase:
Phase 2
Details
Lead Sponsor:
OPKO Health, Inc.
OPKO Ireland Global Holdings Ltd.
Treatments:
Calcifediol